Chetah and colleagues found that co-culturing of LNCaP prostate cancer cells with primary human CAFs or CAF CM reduced p53 in prostate cancer cells, which inhibited drug-induced ROS in response to doxorubicin, taxol or mitomycin C to promote cell survival [278]. Here, TP53 is linked to Familial prostate cancer.